Search Results 431-440 of 16106 for Stub

  1. Mayo Clinic

    ... . IMG-20475909. Home; cc-honey-black-background-tablet. Don't miss your chance! Give Now! Give by Dec. 31 to multiply your impact 3×.

  2. Back pain - Doctors and departments - Mayo Clinic

    Back pain is one of the most common reasons people seek medical help. Home treatment and proper body mechanics often can treat back pain within a few weeks.

  3. A Study of Atezolizumab (Anti-Programmed Death-Ligand 1 [PD-L1] Antibody) in Combination With Carboplatin Plus (+) Nab-Paclitaxel Compared With Carboplatin + Nab-Paclitaxel in Participants With Non-Squamous Non-Small Cell Lung Cancer (NSCLC) (IMpower130) - Mayo Clinic

    Clinical Trials · A Study of Atezolizumab (Anti-Programmed Death-Ligand 1 [PD-L1] Antibody) in Combination With Carboplatin Plus (+) Nab-Paclitaxel Compared With ...

  4. Stroke - Doctors and departments - Mayo Clinic

    Promptly spotting stroke symptoms leads to faster treatment and less damage to the brain.

  5. CLEOPATTRA: A Research Study To Look At The Effects Of Treatment With A Medicine Called Coramitug (NNC6019-0001) In People With Heart Failure Due To Transthyretin Amyloid (ATTR) Amyloidosis - Mayo Clinic

    This study will find out if a new medicine called NNC6019-0001 can help reduce the risk of heart-related death and illness in participants with a condition ...

  6. Spinal stenosis - Doctors and departments - Mayo Clinic

    This condition narrows the amount of space within the spine. This can squeeze the nerves that travel through the spine. Surgery is sometimes needed.

  7. Stroke - Doctors and departments - Mayo Clinic

    Promptly spotting stroke symptoms leads to faster treatment and less damage to the brain.

  8. Safety and Efficacy of Selonsertib, GS-0976, GS-9674, and Combinations in Participants With Bridging Fibrosis or Compensated Cirrhosis Due to Nonalcoholic Steatohepatitis (NASH) - Mayo Clinic

    Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...

  9. A Study to Evaluate the Effectiveness and Safety of Vibegron Administered Orally for 12 Weeks to Women with Irritable Bowel Syndrome - Mayo Clinic

    The purpose of this study is to evaluate the effectiveness and safety of vibegron, a beta-3 adrenergic receptor (β3-AR) agonist, in the treatment of pain ...

  10. Publications - Ryan W. Stidham, M.D. - Mayo Clinic

    Stidham RW, Ghanem LR, Fletcher JG, Bruining DH. Artificial Intelligence-Enabled Clinical Trials in Inflammatory Bowel Disease: Automating and Enhancing Disease ...